Why big pharma wants to collect 2 million genomes
Wednesday, September 28, 2016 - 10:21
in Biology & Nature
For the head of AstraZeneca’s genomics initiative, the challenge is not just getting the sequences, but in putting them to use — wisely.Nature News doi: 10.1038/nature.2016.20697